| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0002 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0003 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0009 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.001 |